As the medical policies and procedures related to COVID-19 adapt to new information, so must the services we provide our clients. Pharma-Safe is proud to announce the addition of services as an Authorized Telehealth Proctor.
This certification will allow Pharma-Safe to assist employers in following the new Emergency Temporary Standard (ETS) announced by the Department of Labor’s (DOL) Occupational Safety and Health Administration (OSHA) last week.
These regulations present business owners with an important choice on who to make responsible for COVID-19 testing.
Though it may seem like a cost-saving measure to have your employees responsible for their own testing, potential liability and outbreaks related to lax reporting may cost you in the long run. With issues in the supply chain affecting test availability, employees may have issues acquiring a test. This is in addition to the risk of deceptive results reporting from those concerned about missing work.
Creating a system of COVID-19 policies and procedures for testing is no easy task, it can also present issues of liability for your business. According to the ETS, all testing must take place in the presence of an employer or Authorized Telehealth Proctor and ETS guidance must be followed to the letter with a $14,000 fee for non-compliance. This is just one of the many requirements in the ETS. Can your business afford the time required to have a person fill this role in-house?
As an Authorized Telehealth Proctor, Pharma-Safe has the certifications and experience needed to create a custom COVID-19 testing plan to fit your business needs. Structured testing is one of the best ways to maintain a healthy workplace ensuring business continuity. As the party responsible for your testing procedures, your business is free from liability related to the ETS.
Pharma-Safe can help avoid these costly fees by ensuring:
- Professional Telehealth testing via a trained proctor
- All employees are tested on time and properly according to the ETS
- Proper steps are taken following a non-negative test result including guidance on quarantine, follow-up testing and returning to work.
The binding requirements of the ETS go into effect in January 2022. As we head into another year of COVID-19 regulations, we look forward to the opportunity to help keep your business healthy. Contact Pharma-Safe to discuss a custom care plan for your business.